WO2013006000A3 - Method for detecting breast cancer using respiratory gas - Google Patents

Method for detecting breast cancer using respiratory gas Download PDF

Info

Publication number
WO2013006000A3
WO2013006000A3 PCT/KR2012/005348 KR2012005348W WO2013006000A3 WO 2013006000 A3 WO2013006000 A3 WO 2013006000A3 KR 2012005348 W KR2012005348 W KR 2012005348W WO 2013006000 A3 WO2013006000 A3 WO 2013006000A3
Authority
WO
WIPO (PCT)
Prior art keywords
breast cancer
respiratory gas
patient
present
progression
Prior art date
Application number
PCT/KR2012/005348
Other languages
French (fr)
Korean (ko)
Other versions
WO2013006000A2 (en
Inventor
라정찬
허재욱
김수현
Original Assignee
주식회사 알앤엘내츄럴
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 알앤엘내츄럴 filed Critical 주식회사 알앤엘내츄럴
Publication of WO2013006000A2 publication Critical patent/WO2013006000A2/en
Publication of WO2013006000A3 publication Critical patent/WO2013006000A3/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/497—Physical analysis of biological material of gaseous biological material, e.g. breath
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/08—Detecting, measuring or recording devices for evaluating the respiratory organs
    • A61B5/082—Evaluation by breath analysis, e.g. determination of the chemical composition of exhaled breath
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/62—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating the ionisation of gases, e.g. aerosols; by investigating electric discharges, e.g. emission of cathode
    • G01N27/622—Ion mobility spectrometry
    • G01N27/623—Ion mobility spectrometry combined with mass spectrometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57415—Specifically defined cancers of breast

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Microbiology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Electrochemistry (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)

Abstract

The present invention relates to a method for detecting breast cancer or the progression of breast cancer using respiratory gas, and more specifically, to a method for detecting breast cancer or the progression of breast cancer by analyzing respiratory gas using an electronic nose. In addition, the present invention relates to a method for providing information on the diagnosis of breast cancer or the progression of breast cancer by analyzing respiratory gas using an electronic nose. According to the present invention, when analyzing the collected respiratory gas using an electronic nose a normal person, an early stage breast cancer patient with stage 0 breast cancer, a patient with only a breast cancer tumor, a patient with breast cancer and other cancers (thyroid cancer), and a patient under anticancer therapy show different patterns, respectively, the present invention is useful when early diagnostic methods are not adequate and to enhance sensitivity and specificity which are the limitations of conventional breast cancer detection
PCT/KR2012/005348 2011-07-05 2012-07-05 Method for detecting breast cancer using respiratory gas WO2013006000A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20110066602 2011-07-05
KR10-2011-0066602 2011-07-05

Publications (2)

Publication Number Publication Date
WO2013006000A2 WO2013006000A2 (en) 2013-01-10
WO2013006000A3 true WO2013006000A3 (en) 2013-04-11

Family

ID=47437572

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2012/005348 WO2013006000A2 (en) 2011-07-05 2012-07-05 Method for detecting breast cancer using respiratory gas

Country Status (2)

Country Link
KR (1) KR20130005247A (en)
WO (1) WO2013006000A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101956346B1 (en) * 2018-05-09 2019-03-08 서울대학교산학협력단 Compositions for Diagnosing of cancer using Volatile Organic Compounds
JP2022509847A (en) * 2018-11-28 2022-01-24 ナショナル ユニバーシティ オブ シンガポール How to detect cancer and / or tuberculosis

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100946436B1 (en) * 2007-09-04 2010-03-10 김성수 Apparatus and method for early disease diagnosis using expired gas
US20100198521A1 (en) * 2007-07-24 2010-08-05 Technion Research And Development Foundation Ltd. Chemically sensitive field effect transistors and uses thereof in electronic nose devices

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100198521A1 (en) * 2007-07-24 2010-08-05 Technion Research And Development Foundation Ltd. Chemically sensitive field effect transistors and uses thereof in electronic nose devices
KR100946436B1 (en) * 2007-09-04 2010-03-10 김성수 Apparatus and method for early disease diagnosis using expired gas

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
PHILLIPS, MICHAEL ET AL., THE BREAST JOURNAL, vol. 9, no. 3, 2003, pages 184 - 191 *
SCOTT, CHERYL SIEGEL ET AL., ENVIRONMENTAL HEALTH PERSPECTIVES, vol. 114, no. 9, September 2006 (2006-09-01), pages 1471 - 1478 *

Also Published As

Publication number Publication date
WO2013006000A2 (en) 2013-01-10
KR20130005247A (en) 2013-01-15

Similar Documents

Publication Publication Date Title
WO2012170478A3 (en) Methods and kits for detecting adenomas, colorectal cancer, and uses thereof
WO2010017515A3 (en) Breast cancer specific markers and methods of use
WO2012135844A3 (en) Circulating exosomes as diagnostic/prognostic indicators and therapeutic targets of melanoma and other cancers
MX2013002084A (en) Biomarkers and methods of treatment.
TN2013000358A1 (en) Fgfr and ligands thereof as biomarkers for breast cancer in hr positive subjects
MX356986B (en) Method for detecting nucleosome adducts.
WO2015109263A3 (en) Biomarkers for detecting and monitoring colon cancer
WO2015094995A3 (en) Gene signature biomarkers of tumor response to pd-1 antagonists
WO2013096845A3 (en) Methods for diagnosis of lung cancer
EP2558598A4 (en) Biomarkers based on a multi-cancer invasion-associated mechanism
WO2013056178A3 (en) Novel estrogen receptor mutations and uses thereof
WO2011141765A8 (en) Diagnostic classifications of pulse signal waveform data
MY182773A (en) Method for indicating a presence or non-presence of aggressive prostate cancer
MX361058B (en) Methods for detecting 5t4-positive circulating tumor cells and methods of diagnosis of 5t4-positive cancer in a mammalian subject.
WO2013175314A3 (en) System and method for detecting preeclampsia
MX2009012386A (en) Labelled hgf binding peptides for imaging.
NZ625969A (en) Discrimination of cheyne-stokes breathing patterns
WO2014140896A3 (en) Method for the diagnosis, prognosis and treatment of cancer metastasis
NZ707116A (en) Ly75 as cancer therapeutic and diagnostic target
SG165370A1 (en) Method for the diagnosis of colorectal cancer and ovarian cancer by the measurement of vitamin e-related metabolites
WO2010120942A3 (en) Histone modification patterns for clinical diagnosis and prognosis of cancer
WO2011027310A8 (en) Novel tumor markers
WO2014028862A9 (en) Use of dna in circulating exosomes as a diagnostic marker for metastasic disease
NZ603780A (en) Blood plasma biomarkers for bevacizumab combination therapies for treatment of breast cancer
WO2009083780A8 (en) Breast cancer expression profiling

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC - FORM 1205A (28.04.2014)

122 Ep: pct application non-entry in european phase

Ref document number: 12807123

Country of ref document: EP

Kind code of ref document: A2